Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,073Revenue (TTM) $M633Net Margin (%)-10.3Altman Z-Score8.4
Enterprise Value $M5,904EPS (TTM) $-0.8Operating Margin %-12.4Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.5Pre-tax Margin (%)-12.7Higher ROA y-yY
Price/Book17.210-y EBITDA Growth Rate %-15.4Quick Ratio5.8Cash flow > EarningsY
Price/Sales9.45-y EBITDA Growth Rate %-4.1Current Ratio6.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-13.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-22.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M86.6ROIC % (ttm)-40.1Gross Margin Increase y-yY

Gurus Latest Trades with DXCM

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

DXCM is held by these investors:



DXCM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Balo Andrew KEVP, Reg. Strategy, Clinical 2017-09-11Sell3,244$72.27-3.89view
Pacelli Steven RobertEVP, Strategy & Corp. Dev. 2017-08-23Sell3,987$75.26-7.71view
DOUBLEDAY RICHARDEVP, Chief Commercial Officer 2017-08-23Sell1,635$75.26-7.71view
SAYER KEVIN RPresident & CEO 2017-08-11Sell6,000$69.77-0.44view
Balo Andrew KEVP, Reg. Strategy, Clinical 2017-08-10Sell3,244$71.18-2.42view
Pacelli Steven RobertEVP, Strategy & Corp. Dev. 2017-07-24Sell1,450$69.47-0.01view
SAYER KEVIN RPresident & CEO 2017-07-12Sell6,000$71.86-3.34view
Balo Andrew KEVP, Reg. Strategy, Clinical 2017-07-10Sell3,200$71.55-2.92view
DOUBLEDAY RICHARDEVP, Chief Commercial Officer 2017-06-23Sell3,187$78.22-11.2view
Pacelli Steven RobertEVP, Strategy & Corp. Dev. 2017-06-23Sell1,450$78.19-11.17view

Quarterly/Annual Reports about DXCM:

News about DXCM:

Articles On GuruFocus.com
DarioHealth: Disruption Is Valuable Jun 07 2017 
7 of the Worst-Performing Stocks in Gurus' Portfolios Apr 14 2017 
Weekly CFO Sells Highlight Jun 28 2016 
Baron Funds Comments on DexCom Inc. Jan 14 2016 
Investing for Lower Risk Long-Term Growth in a Volatile Asset Class - Baron Funds Winter Newsletter Jan 14 2016 
Top Weekly Insider Sells Highlights Sep 15 2015 
Weekly CFO Sells Highlight: Gilead Sciences, DexCom, and Palo Alto Networks Sep 13 2015 
Panic-Proofing the Small Investor Aug 26 2015 
Baron Funds Comments on DexCom Inc. Aug 19 2015 
Weekly CFO Sells Highlight: Cigna Corp, Comcast Corp, and DexCom Inc. Jul 20 2015 

More From Other Websites
Fitbit Inc (NYSE:FIT) Stock Still Has A Lot of Work To Do Sep 19 2017
DexCom Opens Data Platform and Launches Developer Program to Fuel Diabetes App Innovation Sep 19 2017
Why Fitbit Inc (FIT) Stock Is Rising on the Latest Ionic Update Sep 12 2017
DexCom, Inc. breached its 50 day moving average in a Bullish Manner : DXCM-US : September 12, 2017 Sep 12 2017
See what the IHS Markit Score report has to say about Dexcom Inc. Sep 12 2017
Fitbit Investors Are Getting Too Excited About This Announcement Sep 09 2017
DexCom Announces Upcoming Conference Presentation Sep 08 2017
Fitbit shares close up 10% on diabetes-monitoring partnership in new smartwatch Sep 08 2017
Fitbit shares jump following a partnership with diabetes-tracking DexCom Sep 07 2017
Why Fitbit Stock Is Soaring Today Sep 07 2017
Fitbit shares jump almost 10% on news to work with Dexcom on diabetes product Sep 07 2017
Fitbit and Dexcom to Develop Continuous Glucose Monitoring (CGM) Experience for People Living with... Sep 07 2017
Why Is DexCom (DXCM) Up 11.6% Since the Last Earnings Report? Sep 01 2017
DexCom, Inc. – Value Analysis (NASDAQ:DXCM) : August 25, 2017 Aug 25 2017
New Study Shows People with Type 2 Diabetes Benefit from Continuous Glucose Monitoring Aug 21 2017
DexCom, Inc. breached its 50 day moving average in a Bullish Manner : DXCM-US : August 17, 2017 Aug 17 2017
Earnings Review and Free Research Report: DexCom’s Q2 Top-line Surged 24%; Outshined Forecasts Aug 17 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}